Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 09, 2024

BUY
$5.47 - $11.38 $195,826 - $407,404
35,800 New
35,800 $239,000
Q2 2023

Aug 08, 2023

BUY
$7.14 - $9.29 $714 - $928
100 Added 1.32%
7,700 $70,000
Q1 2023

May 15, 2023

BUY
$6.65 - $10.69 $49,875 - $80,175
7,500 Added 7500.0%
7,600 $56,000
Q4 2022

Feb 14, 2023

BUY
$5.96 - $8.53 $596 - $852
100 New
100 $0

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $4.51B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.